Neogen Chemicals Completes ₹161 Crore Preferential Allotment to Cadamba Solutions

Neogen Chemicals Limited has successfully completed its preferential allotment of 10,00,000 equity shares to Cadamba Solutions Private Limited, raising ₹161 crore. The Fund Raising Committee of the Board of Directors approved the allotment on April 18, 2026, following regulatory approvals from both BSE Limited and National Stock Exchange of India Limited received on April 17, 2026.

Allotment Details and Pricing

The equity shares, with a face value of ₹10 each, were allotted at ₹1,610 per share, including a premium of ₹1,600 per share. The issue price represents a 17.02% premium above the floor price of ₹1,375.82, calculated in accordance with Regulation 164 of the SEBI ICDR Regulations.

Parameter: Details Total Shares Allotted: 10,00,000 Issue Price: ₹1,610 per share Premium: ₹1,600 per share Total Amount Raised: ₹161,00,00,000 Floor Price: ₹1,375.82 Premium over Floor Price: 17.02%

Shareholding Impact

Following the allotment, the company's issued, subscribed, and paid-up equity share capital increased from ₹26,38,16,740 to ₹27,38,16,740. Cadamba Solutions Private Limited, categorized as a Promoter Group Member, now holds 10,00,000 equity shares representing 3.65% of the company's total share capital.

Shareholding Details: Pre-Allotment Post-Allotment Cadamba Solutions Holdings: 0 shares (0%) 10,00,000 shares (3.65%) Company Share Capital: ₹26,38,16,740 ₹27,38,16,740

Regulatory Compliance and Lock-in

The allotted equity shares will be listed on both BSE Limited and National Stock Exchange of India Limited, ranking pari passu with existing equity shares in all respects, including dividend payment and voting rights. The shares are subject to lock-in requirements under Regulation 167 of the SEBI ICDR Regulations, with equity shares allotted to the promoter group category locked in for 18 months from the date of trading approval.

The preferential issue was conducted pursuant to the Special Resolution passed by members at the Extraordinary General Meeting held on March 29, 2026. The company confirmed that there has been no cancellation or termination of the proposal for issuance of securities, ensuring the successful completion of this capital raising initiative.

Axis Trustee Services Limited has disclosed receiving 20,19,167 equity shares of Neogen Chemicals as pledged securities, representing 7.65% of the company's paid-up capital. The disclosure was made under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, in their capacity as debenture trustee.

Regulatory Disclosure and Trustee Role

Axis Trustee Services Limited submitted the mandatory disclosure to both BSE Limited and National Stock Exchange of India Limited on April 14, 2025. The trustee clarified that they hold no beneficial interest in the pledged shares and received them solely in their capacity as debenture trustee pursuant to SEBI regulations.

Parameter: Details Shares Pledged: 20,19,167 equity shares Percentage of Capital: 7.65% Pledge Date: April 13, 2026 Trustee Entity: Axis Trustee Services Limited Total Share Capital: 2,63,81,674 shares

Share Pledge Transaction Details

The pledge creation involves Dr. Harin Haridas Kanani, a promoter of Neogen Chemicals, who pledged the shares to facilitate borrowing and fund raising by Cadamba Solutions Private Limited, a promoter group member. Prior to this transaction, Axis Trustee Services Limited held no shares or encumbrances in Neogen Chemicals.

Before Pledge: Holdings After Pledge: Holdings Voting Rights: NIL Voting Rights: NIL Encumbered Shares: NIL Encumbered Shares: 20,19,167 (7.65%) Total Holdings: NIL Total Holdings: 20,19,167 (7.65%)

Promoter Holdings Structure

Dr. Harin Haridas Kanani maintains significant holdings in Neogen Chemicals with 33,38,250 shares representing 12.65% of total share capital. The promoter group structure includes multiple family trusts and individual holdings across the Kanani family members.

Promoter Entity: Shareholding Percentage Haridas Kanani Family Trust: 52,76,500 shares 20.00% Dr. Harin Haridas Kanani: 33,38,250 shares 12.65% Beena Kanani Family Trust: 26,38,250 shares 10.00% Pallika Haridas Kanani: 9,98,000 shares 3.78%

Compliance and Market Information

The disclosure demonstrates adherence to SEBI's transparency requirements for substantial shareholding changes and encumbrance creation. Neogen Chemicals shares are listed on both major Indian stock exchanges, with the company maintaining a total equity share capital of 2,63,81,674 shares as per the latest shareholding pattern for the quarter ended December 2025. The transaction reflects the interconnected financial arrangements within promoter group structures while ensuring regulatory compliance through proper trustee mechanisms.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.